483
John C. Lieske, M.D., Clinical InvestigatorFDA 483 - John C. Lieske, M.D., Clinical Investigator - March 03, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of John C. Lieske, M.D., Clinical Investigator in Rochester, MN, revealed significant deficiencies in adverse event reporting. The firm failed to report serious adverse events, including those involving hospitalization, to the study sponsor as required by protocol. Additionally, non-serious adverse events were not reported to the sponsor in accordance with the study protocol's specified timetable.
Open in Dashboard
ID · 7f5ffbe9-e1dc-4da0-9ff5-4d0979ebbb87